Optimizing BM harvesting from normal adult donors

被引:31
作者
Lannert, H. [1 ]
Able, T. [1 ]
Becker, S. [2 ]
Sommer, M. [2 ]
Braun, M. [2 ]
Stadtherr, P. [1 ]
Ho, A. D. [1 ]
机构
[1] Heidelberg Univ, Med Clin, Dept Hematol Oncol & Rheumatol, D-69120 Heidelberg, Germany
[2] Cytonet Heidelberg, Heidelberg, Germany
关键词
BM harvest; stem cell collection; collection time; allogeneic transplantation;
D O I
10.1038/bmt.2008.196
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
The experience at a single institution of BM harvesting (BMH) in general anesthetic for allogeneic trans plantation from 49 healthy adult donors since March 2002 is presented in detail, together with an analysis of all the donor complications. In this study, we analyzed the advantages through the change from an aspiration needle with one hole (group A, n = 18) to a system with additional five side holes (group B, n = 31) in April 2005 for faster aspiration of large volumes of BM. In group B, the operation time was reduced by 50%, which is 12 min to date (1006 ml BM). Furthermore, the collection rate (volume BM/time) was significantly increased, namely to 81.9 ml/min in group B. The yields of total nucleated cells and CD34+ cells are nearly identical and adequate in both systems. The proportion of donors treated as day cases-that is, able to be discharged on the same day as the procedure-was 56% in group A and 81% in group B. There was no significant operative site morbidity. BMH accomplished by trained personal is a safe procedure for healthy adult donors on an outpatient basis as standard in our collection center.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 15 条
[1]
Performing bone marrow harvest on an outpatient basis: A single center UK experience [J].
Aleem, A ;
Lovell, R ;
Holder, K ;
Chakarbarti, S ;
James, J ;
Milligan, DW .
ACTA HAEMATOLOGICA, 2004, 112 (04) :200-202
[2]
BACIGALUPO A, 1992, BONE MARROW TRANSPL, V9, P467
[3]
BATINIC D, 1990, BONE MARROW TRANSPL, V6, P103
[4]
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project [J].
Bennett, Charles L. ;
Evens, Andrew M. ;
Andritsos, Leslie A. ;
Balasubramanian, Lakshmi ;
Mai, Mark ;
Fisher, Matthew J. ;
Kuzel, Timothy M. ;
Angelotta, Cara ;
Mckoy, June M. ;
Vose, Julie M. ;
Bierman, Philip J. ;
Kuter, David J. ;
Trifilio, Steven M. ;
Devine, Steven M. ;
Tallman, Martin S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (05) :642-650
[5]
BOLWELL BJ, 1995, BONE MARROW TRANSPL, V16, P703
[6]
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation [J].
Dominietto, A ;
Lamparelli, T ;
Raiola, AM ;
Van Lint, MT ;
Gualandi, F ;
Berisso, G ;
Bregante, S ;
di Grazia, C ;
Soracco, M ;
Pitto, A ;
Frassoni, F ;
Bacigalupo, A .
BLOOD, 2002, 100 (12) :3930-3934
[7]
Differences between graft product and donor side effects following bone marrow or stem cell donation [J].
Favre, G ;
Beksaç, M ;
Bacigalupo, A ;
Ruutu, T ;
Nagler, A ;
Gluckman, E ;
Russell, N ;
Apperley, J ;
Szer, J ;
Bradstock, K ;
Buzyn, A ;
Matcham, J ;
Gratwohl, A ;
Schmitz, N .
BONE MARROW TRANSPLANTATION, 2003, 32 (09) :873-880
[8]
Unrelated allogeneic bone marrow donation: short- and long-term follow-up of 103 consecutive volunteer donors [J].
Gandini, A ;
Roata, C ;
Franchini, M ;
Agostini, E ;
Guizzardi, E ;
Giacometti, PP ;
Vassanelli, A ;
Rocca, P ;
Zanuso, C ;
Fasolo, R ;
de Gironcoli, M ;
Gandini, G ;
Benedetti, F ;
Aprili, G .
BONE MARROW TRANSPLANTATION, 2001, 28 (04) :369-374
[9]
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products [J].
Gratwohl, A. ;
Baldomero, H. ;
Frauendorfer, K. ;
Rocha, V. ;
Apperley, J. ;
Niederwieser, D. .
BONE MARROW TRANSPLANTATION, 2008, 41 (08) :687-705
[10]
Allogeneic hematopoietic stem cell transplantation:: state of the art and new perspectives [J].
Ringdén, O ;
Le Blanc, K .
APMIS, 2005, 113 (11-12) :813-830